張家界(000430.SZ)擬清算並註銷文創公司
格隆匯 8 月 17日丨張家界(000430.SZ)公佈,公司於2020年8月17日召開第十屆董事會2020年第三次臨時會議,審議通過了《關於擬清算並註銷控股子公司的議案》,同意清算並註銷公司控股子公司安張家界中工美旅遊文創有限公司(“文創公司”)。
文創公司主營業務為旅遊紀念品的開發、生產、銷售。近些年來,遊紀念品市場競爭激烈,產品同質化程度高,文創公司很難打開市場,導致文創公司持續虧損。
鑑於目前文創公司仍無法扭轉虧損局面,且虧損局面有進一步惡化的趨勢,對文創公司進行清算註銷,有助於公司及時止損,減少進一步虧損的風險,有利於增強公司持續發展能力,符合公司中長期利益和廣大股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.